Table 1.

Clinical/pathological characteristics of the patients^a (n =36)

Characteristic	Number (%)
Age (median, range)	57(37–72)
Stage (FIGO)
III	31(85%)
IVA	5(15%)
Debulking Status
Optimal (≤1 cm)	24(66%)
Suboptimal (>1 cm)	12(34%)
Histological type
Serous	32(90%)
Endometriod	2(5%)
Clear cell	2(5%)
Grade
2	7(20%)
3	29(80%)

^aAll patients received standard adjuvant platinum/taxane-based chemotherapy.